Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 2, 2017
Patent Application Number
15130603
Date Filed
April 15, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention is directed to inhibitors of histone deacetylases (HDACs) such as HDAC6 and HDAC11, and their use in the treatment of diseases such as cell proliferative diseases (e.g., cancer), neurological (e.g., neurodegenerative disease or neurodevelopmental disease), inflammatory or autoimmune disease, infection, metabolic disease, hematologic disease, or cardiovascular disease.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
